Web20 sept. 2024 · Scholar Rock (NASDAQ: SRRK), a Phase 3, clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that its Board of Directors appointed Jay Backstrom, M.D., M.P.H., as Chief Executive Officer-Elect, effective … WebJay Backstrom. Age : 67. Public asset : 1,815,000 USD. Country of residence : Unknown. Linked companies : Scholar Rock Holding Corporation - Disc Medicine Opco Inc - LAVA …
Les Oilers et les Kings ont rendez-vous au premier tour
Web4 aug. 2024 · Dr. Backstrom currently serves as EVP, Head of Research & Development at Acceleron, a role that he has held since December 2024. Prior to that, he spent 10 years at Celgene where he latterly served as Chief Medical Officer and Head of Regulatory Affairs with a focus in hematology/oncology. WebMr. Backstrom has over 25 years of consulting experience focused exclusively in the healthcare provider market, including more than 10 years leading and addressing … online trading canada
2024-21 Upper Deck UD Exclusives Nicklas Backstrom 032/100 …
Web20 sept. 2024 · Dr. Backstrom has a unique combination of clinical research and development, regulatory, and leadership experience, which spans 30 years across the biopharmaceutical industry. He has been... WebView Jay Backstrom results including current phone number, address, relatives, background check report, and property record with Whitepages. ... WebTashaa Backstrom is on Facebook. Join Facebook to connect with Tashaa Backstrom and others you may know. Facebook gives people the power to share and makes the world more open and connected. is bruce springsteen still sick